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ABSTRACT 
 
Although more than 150 years have past since the discovery of general 
anesthetics, how they precisely work remains a mystery. We propose a novel 
unitary mechanism of general anesthesia verifiable by experiments. In the 
proposed mechanism, general anesthetics perturb oxygen pathways in both 
membranes and oxygen-utilizing proteins such that the availabilities of oxygen to 
its sites of utilization are reduced which in turn triggers cascading cellular 
responses through oxygen-sensing mechanisms resulting in general anesthesia. 
Despite the general assumption that cell membranes are readily permeable to 
oxygen, exiting publications indicate that these membranes are plausible oxygen 
transport barriers. The present hypothesis provides a unified framework for 
explaining phenomena associated with general anesthesia and experimental 
results on the actions of general anesthetics. If verified by experiments, the 
proposed mechanism also has other significant medical and biological 
implications. 
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INTRODUCTION 
 
General anesthetics affect a variety of ion channels and neurotransmitter 
receptor subtypes (1-7). They even affect actin-based motility in dendritic spines 
(8).  However, how they precisely work remains a mystery. There are mainly two 
schools of thoughts on how they work but neither is universally accepted. 
The first and the oldest is the “lipid theory” which proposes that 
anesthetics dissolve into cell membranes and produce common structural 
perturbation resulting in depressed function of ion channels and receptors that are 
involved in brain functions (9-14). However, there has been no direct 
experimental evidence to support the notion that anesthetic perturbation of 
membrane depresses functions of membrane proteins. 
The second, more popular and recent theory is the “protein theory” 
which suggests that anesthetics directly interact with membrane proteins such as 
ion channels and receptors that are involved in brain functions (15-17). But again 
there is no direct experimental evidence, e.g., that obtained by applying any of 
the established essays, such as radioligand-binding essay, to support the notion 
that general anesthetics specifically bind to these ion channels and receptors. In 
addition, this theory doesn't seem to square well with the low affinity and 
diversity of the general anesthetics. 
Overall, it seems that each theory has its merits and may be partially 
correct. The lipid theory may be correct on the notion that membrane 
perturbation is related to anesthesia but incorrect on the notion that membrane 
perturbation depresses the functions of ion channels and receptors involved in 
brain functions. On the other hand, the protein theory may be correct on the 
notion that specific bindings of certain substances on ion channels and receptors 
involved in brain functions are related to anesthesia but incorrect on the notion 
that general anesthetics specifically bind to these proteins. Therefore, finding the 
missing link between these two types of theories may be the key to solve this 
150-year old medical mystery. 
We postulate that the diverse effects of general anesthetics observed at 
the cellular level (see 1-7) are all cascading cellular responses triggered by the 
change in the availability, at molecular level, of a biochemical component 
essential to consciousness and other brain functions which in turn is caused by 
the anesthetic perturbations of the pathways of that component in both 
membranes and proteins. 
We further speculate that oxygen is such a biochemical component 
because it provides one of the essential components necessary for energy 
production in the brain cells. The most immediate purpose of our respiratory and 
circulatory systems is to deliver oxygen to the tissue for use by mitochondria, and 
to eliminate carbon dioxide. Further, although the brain represents only 2% of the 
body weight, it receives 15% of the cardiac output, 20% of total oxygen 
consumption, and 25% of total body glucose utilization (18). 
The transport of oxygen from the brain tissue to the mitochondria in the 
brain cells, where it is consumed and energy is produced, is presumably governed 
by the physical law of diffusion (19).  As discussed later, contrary to the general 
assumption that cell membranes are readily permeable to oxygen, existing 
publications support the notion that these membranes are plausible oxygen 
transport barriers. The lateral movement of oxygen within the membrane to 
oxygen-utilizing protein may also encounter barriers. Further, the movement of 
oxygen in the protein to its site of utilization such as movement in a hydrophobic 
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pocket may also encounter barriers. Since both molecular oxygen and general 
anesthetics are hydrophobic, we speculate that the latter perturb the pathways of 
the former in both membranes and proteins. 
In essence, we postulate that general anesthetics perturb oxygen 
pathways in both membranes and proteins such that its availabilities to the sites 
of utilization are reduced which in turn triggers cascading cellular responses 
through oxygen-sensing mechanisms resulting in general anesthesia. 
The present hypothesis provides a unified framework for explaining 
phenomena associated with general anesthesia and experimental results on the 
actions of general anesthetics. If valid, the proposed mechanism also has other 
significant medical and biological implications. 
 
 
 
PHYSICS OF OXYGEN TRANSPORT 
 
Movement of small neutral molecules such as O2 across membranes 
typically occurs by diffusion, a form of random motion powered by thermal 
vibrations (19). O2 has to diffuse through the plasma membrane and the outer and 
inner membranes of the mitochondria before it can reach the mitochondrial 
matrix. (Fig.1a). 
 At each membrane, O2 has to diffuse through a first polar surface region, 
a hydrophobic region and a second polar surface region (Fig.1b). The free energy 
barrier for O2 uptake is also schematically shown in Figure 1b. Thus, although O2 
may diffuse through the hydrophobic region without too much difficulty, it needs 
much more thermal energy to diffuse through the polar surface region at each 
side of the membrane (19). 
 For a membrane separating two solution of concentration [O2]1aq and 
[O2]2aq, where [O2]1aq > [O2]2aq (Figure 1b), the O2 diffusion rate across the 
membrane is given by the modified Fick’s law: 
 
J=P([O2]1aq-[O2]2aq)              [1] 
where P is the O2 permeability coefficient of the membrane. It is proportional to 
O2 partition coefficient K and diffusion coefficient D of the membrane and is 
inversely proportional to membrane thickness x (20), or 
P=K(D/x)                   [2] 
Thus, the diffusion rate of O2 across the membrane is proportional to its 
diffusion coefficient D and partition coefficient K. It follows that if a substance 
significantly reduces D and/or K it may cause hypoxia or oxygen-limiting 
situations to develop at cellular or sub-cellular level. 
In a simplified model, one can directly relate O2 permeability coefficient 
P of a membrane to the percentage of “ holes”  on the membrane (21). To do this 
one treats the membrane as an infinitely thin reflecting wall with homogeneously 
distributed holes. Further, let D be the ratio of the total surface of all holes to the 
membrane surface (21). It can be shown then: 
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J=D(1-D )-1[(kbT)(2Sm)-1]1/2([O2]1aq-[O2]2aq)  [3] 
Compare equation [3] to equation [1], one gets: 
P=D(1-D)-1[(kbT)(2Sm)-1]1/2    [4] 
where T, kb and m denote temperature, Boltzmann constant and mass of O2 
respectively (21).  
Thus, in the simplified model, the diffusion rate of O2 across the 
membrane is directly related to the percentage of holes on the membrane. It 
follows that, if a substance significantly reduces D, it may cause hypoxia or 
oxygen-limiting situations to develop at cellular or sub-cellular level. 
 The lateral movement of O2 within the membrane, such as the inner 
membrane of the mitochondria, may also be involved before O2 can reach the O2-
utilizing protein (see Fig.2), such as the cytochrome oxidase complex of the 
Creb’s cycle. The lateral diffusion rate Jm of O2 is presumably subject to the 
Fick’s law: 
Jm =(Dm/d)([O2]1m -[O2]2m)                      [5] 
where [O2]1m and [O2]2m are respectively the O2 concentrations in two regions of 
the membrane ([O2]1m > [O2]2m), Dm is the lateral diffusion coefficient of O2 in 
the membrane, and d is the distance separating the two regions of the membrane.  
Thus, the lateral diffusion rate of oxygen within membrane is 
proportional to its diffusion coefficient Dm. It follows that if a substance 
significantly reduces Dm oxygen-limiting situations may develop near the site of 
O2 utilization. 
Finally, the movement of O2 within the protein such as movement in a 
hydrophobic pocket may also be involved before O2 can reach its site of 
utilization (see Fig.2). Conceivably, any substance which blocks, narrows, 
distorts or otherwise interferes with the O2 pathway within the protein may 
reduce oxygen availability to its site of utilization at the molecular level resulting 
in hypoxia-mimic situations. 
 
 
MEMBRANE AS OXYGEN DIFFUSION BARRIER 
In view of the above discussions, it is possible that certain biological 
membranes are oxygen diffusion barriers because of their particular structure-
composition. Neurons are highly irregular cells with a particular membrane 
structure-composition. It is also possible that certain substances significantly 
reduce membrane permeability to O2 by reducing O2 diffusion coefficient and/or 
partition coefficient of the membrane, or, from a different perspective, by 
reducing the percentage of “ holes”  on the membrane.  Further, it is possible that 
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certain substances significantly reduce O2 lateral diffusion coefficient of the 
membrane or otherwise perturb its availability to O2–utilizing proteins. Indeed, 
there are publications supporting these speculations as discussed below. 
Electron paramagnetic resonance (EPR) studies of O2 transport 
parameters in phosphatidylcholine-cholesterol membranes showed that the 
addition of 50 mol % cholesterol decreases oxygen permeability of the 
membrane by a factor of 2.5 to 5 (22). The same study also reported that the main 
resistance to oxygen transport is located in and near the polar surface regions in 
the membrane (22). In an earlier study, it was reported that the addition of an 
equimolar amount of cholesterol into liposomes of egg lecithin decreased the 
partition coefficient of CO2, a small, neutral molecule like O2, by about 25% (20). 
In another report, EPR studies of O2 transport in the CHO cell plasma 
membrane showed that at 37 oC the oxygen permeability coefficient for the 
plasma membrane was about two times lower than for a water layer of the same 
thickness as the membrane (23). Although it was concluded that oxygen 
permeation across the cell plasma membrane could not be a rate-limiting step for 
cellular respiration, [O2] difference in the nanomolar range across the CHO cell 
plasma membrane at physiological conditions does exit (23). 
Classically, there is a direct correlation between the hydrophobic nature 
of a molecule and its rate of permeation across a biological membrane. So cell 
membranes should be more permeable to small, neutral molecules than they are 
to charged molecules of similar sizes. However, it was reported that apical 
membranes of renal tube cells from the medullary thick ascending limb of Henle 
are virtually impermeable to NH3, a small neutral molecule (24). It was suggested 
that such low permeability is due to the specific lipid structure-composition of 
the apical bilayer (24). Thus, since O2 is a small neutral molecule like NH3, it is 
possible that certain biological membranes such as those of the neurons may have 
reduced permeability to O2 due to their structure-composition or changes thereof. 
 Furthermore, it has been repeatedly demonstrated through EPR oxymetry 
that the measurement of extracellular [O2] may not accurately reflect intracellular 
[O2] since the average intracellular [O2] are consistently lower than the average 
extracellular [O2] in quite a few cell suspensions under normal or stimulated 
conditions (25-28).  Thus, contrary to the popular notion that O2 freely diffuses 
through membranes, these publications suggest that biological membranes are 
plausible oxygen diffusion barriers. 
 In addition, it was reported that treatment of sickle red cells with certain 
voltage pulse causes a change in the cell membrane so as to facilitate the 
permeation of O2 (29). This result also suggests that some membranes may have 
low O2 permeability and a modification is possible through external influence. 
 Finally, the study of intracellular supply of O2 to mitochondria by 
measuring the O2 dependence of oxidation of cytochromes has shown that the O2 
diffusion coefficient in the region of mitochondria in situ is considerably small 
and suggests that a significant O2 gradient in the vicinity of mitochondria occurs 
under hypoxic conditions (30). These results suggest that the O2 diffusion rate 
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may be a critical factor for intracellular O2 supply to mitochondria during 
hypoxia (30). 
 
ANESTHETIC PERTURBATION OF MEMBRANE 
 Both theoretical and experimental studies have shown that many general 
anesthetics cause changes in membrane structures and properties at or just above 
the clinical concentrations required for anesthesia (10-14,31). 
 Fore example, it was reported that, with dipalmitoyl-L-D-
phosphatidylcholine (DPPC) vesicle membranes, the main transition temperature 
between the lipid-crystal and solid gel phases decreases by the addition of short 
chain l-alkanols, but increases by long-chain l-alkanols (32). The switchover 
from depression to elevation of the transition temperature occurs at the same 
carbon-chain length as the cutoff point of anesthetic effects of these l-alkanols 
(32). This suggests that the disordering effects of anesthetics on the hydrophobic 
region of the membrane are closely related to anesthesia and its cutoff point. 
 It was also reported that while the lipid order parameter reported by 
nitroxide spin label, 12-doxyl stearate, was decreased by anesthetic alcohols 
(octanol, decanol, and dodecanol), the non-anesthetic alcohols either did not 
change it significantly (tetradecanol) or actually increased it (hexadecanol and 
octadecanol) (12). These results again suggest that the disordering effects of 
these alcohols on the hydrophobic region of the membrane are closely related to 
anesthesia and its cutoff point. 
Not only general anesthetics perturb hydrophobic regions of membranes, 
they also perturb the membrane surface regions by disrupting interfacial 
hydrogen bonding (33). It was reported that the alkanols form hydrogen bonds 
with the phosphate moiety of DPPC and release the DPPC-bound water (33). 
These effects increase with the elongation of the carbon chain of l-alkanols from 
ethonal (C2) to l-decanol (C10) and are linearly related to the anesthetic potencies 
of these alkonols, but suddenly almost disappear at l-tetradecanol (C14) (33). 
Because of the non-specific nature of anesthetic interactions with 
membranes and their surface regions, many physical and biochemical parameters 
may be affected at, or just above, the clinical concentrations (31). The key 
question is which physical or biochemical parameters play an important role in 
the production of anesthesia. 
 
ANESTHETIC PERTURBATION OF PROTEIN 
Because of the low affinity and diversity of the general anesthetics, we 
speculate that their interactions with proteins are mostly in the forms of ligand 
pathway perturbation, not specific binding. More specifically, we propose that 
general anesthetics dissolve into hydrophobic regions of protein complex such as 
 7 
hydrophobic pockets containing ligand-binding sites thus acting as barriers to the 
movement of ligand to said sites. 
Indeed, most proteins are insensitive to the presence of clinically relevant 
concentrations of general anesthetics, while some are affected by certain 
anesthetic agents (34). For example, it was shown that the activity of firefly 
luciferase could be inhibited by 50% at surgical concentrations of various 
anesthetics (34). It was concluded that the inhibition was competitive in nature, 
with anesthetic molecules competing with substrate luciferin molecules for 
binding to the enzyme (34). 
We speculate that these anesthetics dissolve into the hydrophobic pocket 
of the enzyme and perturb the oxygen pathway to its site of utilization. Besides 
luciferin molecules, O2, ATP and Mg+2 are other substrates needed by the 
enzyme to produce light. It should be pointed out that firefly luciferase is a pure 
water-soluble protein and has nothing to do with anesthesia. 
In another report, it was shown that the n-alcohols (C1 to C14) inhibit the 
membrane-bound enzyme cytochrome c (35). The inhibition constants were 
shown to correlate well with the number of carbon atoms in the n-alcohols and 
also their n-octanol/water partition coefficients (35). Thus, it was suggested that 
these n-alcohols inhibit by binding to an octanol-like environment on the enzyme 
or the protein-phospholipid interface (35).  
Again, we speculate that these n-alcohols dissolve into the hydrophobic 
pocket of cytochrome c oxidase complex containing the site of oxygen utilization 
thus perturb the oxygen pathway to said site. This alternative explanation is 
further supported by the finding that neither negatively charged carboxylates nor 
positively charged amine analogues were observed to cause any inhibition (35), 
indicating that the region where inhibition took place is probably hydrophobic. 
Overall, existing publications suggest that general anesthetics seem to 
interact with protein (36) in various weak and probably non-specific forms at 
reasonable pharmacological concentrations. The key question is which 
interactions are relevant to general anesthesia. 
We postulate that general anesthetics perturb oxygen pathways in both 
membranes and proteins resulting in reduced oxygen availability to its sites of 
utilization. 
 
 
OXYGEN PATHWAY PERTURBATION HYPOTHESIS 
 The mechanism of general anesthesia according to the present hypothesis 
is schematically shown in Fig. 3. As soon as general anesthetics are absorbed into 
brain cells, they immediately act as O2 transport barriers by narrowing, blocking, 
dislocating, distorting or otherwise interfering with the O2 pathways in both 
membranes and proteins (Fig. 2) such that its availabilities to the sites of 
utilization are reduced. The reduced availabilities of O2 may be reflected by 
hypoxia or hypoxia-mimic situations at cellular or sub-cellular levels. 
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In turn, the reductions of O2 availabilities to the sites of utilization 
activate oxygen-sensing mechanisms of the brain cells through which cascading 
cellular responses are generated in order to reduce brain energy consumption and 
preserve brain functionality resulting in general anesthesia. 
Therefore, according to the present hypothesis, general anesthesia is the 
product of brain self-preservation in response to reductions of O2 availabilities to 
the sites of utilization in brain cells caused by general anesthetics. 
If the present hypothesis is correct, the remaining issues need to be 
resolved are the details of oxygen-sensing mechanisms through which cascading 
cellular responses are generated. They will probably involve the releases of 
various modulating messengers and other signaling processes in order to 
depress/enhance certain excitatory/inhibitory ion channels and receptors involved 
in brain functions. 
 
OXYGEN-SENSING MECHANISMS 
The mechanisms of O2-sensing have been widely studies (37-41). 
Hypoxia elicits a variety of physiological and adaptive responses at cellular and 
sub-cellular levels that requires the existence of an O2 sensor coupled to a 
signaling system, which in turn activates the functional response (37). Much has 
been learned about the signaling systems activated by hypoxia, but the nature of 
the underlying O2-sensor is still unclear (37).  
The consensus is that the mitochondrial respiratory chain is in part the 
site of oxygen sensing (38). They initiate signaling cascades involved in 
physiological and adaptive responses to hypoxia (38). Further, membrane-bound 
NAD(P)H oxidase possibly takes part in oxygen sensing (38). It has also been 
suggested that ion channels may change conductance as a function of [O2], 
allowing them to signal the onset of hypoxia (41).  
The oxygen-sensing mechanisms activated by general anesthetics may or 
may not be similar to those studied so far. 
 
VERIFICATION OF THE HYPOTHESIS 
 The present hypothesis can be verified through several types of 
experiments described below. Additional supporting evidence will also come 
from the application of the hypothesis to phenomena associated with anesthesia 
and experimental results on the actions of general anesthetics as discussed later. 
Measurement of Intracellular [O2] in vitro 
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 According to the present hypothesis, general anesthetics may 
significantly reduce membrane O2 permeability thus causing cellular or sub-
cellular hypoxia. Therefore, by measuring the effect of anesthetics on 
intracellular [O2] of functional neurons in vitro, one can test the validity of the 
hypothesis at the cellular level. 
 There are several methods available for measuring intracellular [O2]. One 
of them is the direct insertion of an intracellular O2 electrode into a single cell 
(42,43). The second method utilizes fluorescence quenching by O2 after the 
fluorescent probe, pyrenebutyric acid, is taken up by the cells (44,45). The third, 
more extensively studied method is the EPR oximetry in which the broadening 
effect of O2 on the intracellular EPR signals of nitroxides is utilized (25-28). 
Measurement of O2 Availability inside Mitochondria 
Even if general anesthetics do not cause hypoxia at the cellular level, 
they may still cause hypoxia or hypoxia-mimic situations inside the mitochondria 
where oxygen is consumed and energy is produced. 
There are several methods available for providing information on the 
availability of O2 to its sites of utilization inside the mitochondria.  One method 
utilizes the measurement of optical absorption by mitochondrial redox couples 
(30,46).  Another method utilizes the measurement of fluorescence from 
mitochondrial redox couples (47,48). The authors here suggest yet a third method 
discussed below.  
It has been shown that the cellular reductions of lipid-soluble nitroxides 
involve the Creb’ s cycle and are sensitive to the availability of O2 (49,50). Thus, 
the lower the availability of O2 to its sites of utilization inside the mitochondria, 
the faster the reduction of a lipid-soluble nitroxide as measured by EPR.  It is 
predicted that if general anesthetics reduce the availability of O2 to its sites of 
utilization inside the mitochondria, the rate of reduction of a lipid-soluble 
nitroxide will increase in the presence of general anesthetics at clinically relevant 
concentrations. 
Measurement of O2 transport parameters within the membrane 
 The effects of anesthetics on O2 transport in the membranes can be 
studied by observing, in the presence and absence of general anesthetics, the 
collision of O2 with nitroxide spin labels placed at various distances from the 
membrane surface using long-pulse saturation recovery EPR techniques (22,23). 
The O2 permeability coefficients of the membrane can be estimated from the 
oxygen transport parameter profiles so obtained (22,23). Further, such profile 
will also provide information on the effect of general anesthetics on the lateral 
diffusion of O2 in the membrane. If the present hypothesis is correct, the 
estimated O2 permeability across the membrane and its lateral diffusion 
coefficient should decrease in the presence of general anesthetics. 
Measurement of Cellular and Sub-cellular [O2] in vivo 
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 There are apparently no suitable methods for directly measuring 
intracellular [O2] in vivo. However, there are various techniques available for 
measuring brain metabolic rate and energy consumption (51,52) that will provide 
indirect information on the availability of O2 to its sites of utilization inside the 
brain cells. The present hypothesis predicts reduced energy consumption and 
depressed overall brain metabolism. Indeed, supporting publications already exist 
as discussed below. 
 
APPLICATION OF THE PRESENT HYPOTHESIS 
The present hypothesis provides a unified framework for explaining 
phenomena associated with general anesthesia and experimental results on the 
actions of general anesthetics. However, due to limited spaces, only several 
examples are given below. 
One of the important phenomena of general anesthesia is the depression 
of cerebral metabolic rate (51). According to the present hypothesis, this 
phenomenon is due to the cascading cellular responses generated through the 
oxygen-sensing mechanisms activated by anesthetic-induced hypoxia or hypoxia-
mimic situations at cellular or sub-cellular level. It is well known that hypoxia 
induces hypometabolism (34-38, 53,54). 
 Secondly, the classical Meyer-Overton correlation that the effectiveness 
of an anesthetic is closely related to its solubility in lipids (9) can also be 
explained according to the present hypothesis. The effectiveness of an anesthetic 
in perturbing the oxygen pathways in membranes and proteins is closely related 
to its solubility in a hydrophobic environment such as the membrane and the 
hydrophobic pocket of a protein complex. As the carbon chain of an anesthetic 
grows, its solubility in the hydrophobic environment increases and so is its 
effectiveness in perturbing the oxygen pathways in membranes and proteins. 
However, when the carbon chain of the anesthetic grow to certain length, 
it cannot dissolve into an hydrophobic pocket of a protein complex due to its 
size, nor can it produce disordering effect in the membrane as shown by 
experiments (12,32,33), thus greatly diminishing its ability to perturb oxygen 
pathways in membranes and proteins. The end result is the disappearance of the 
anesthetic effect as its carbon chain grows to certain length. This is known as the 
anesthesia cut-off phenomenon (see, e.g., 33). 
 As to the “ pressure antagonism”  that high pressure reverses anesthesia 
(55), the present hypothesis can also provide a satisfactory explanation. High 
pressure minimizes anesthetic perturbation of oxygen pathways in membranes 
and proteins by respectively squeezing the anesthetics out of the oxygen 
pathways in the membranes and slowing their movement into the oxygen 
pathways in the proteins. 
The observed effects of general anesthetics on various ion channels and 
receptors (1-7) at cellular level can all be explained according to the present 
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hypothesis as the cascading cellular responses generated through the oxygen-
sensing mechanisms, such as the releases of various modulating messengers, in 
response to reduced O2 availability to the sites of utilization caused by general 
anesthetics. Thus, in the proposed mechanism, ion channels and receptors are the 
direct targets of action by endogenous modulating messengers generated through 
the oxygen-sensing mechanisms but not general anesthetics themselves. 
For example, the widely reported result that anesthetics and n-alcohols 
potentiate the action of the strychinine-sensitive glycine receptor (GlyR) and the 
F-aminobutyric acid type A (GABAA) (see, e.g., 5, 56) can be satisfactorily 
explained as the potentiation of the actions of these receptors by the binding of 
endogenous messengers generated through the oxygen-sensing mechanisms. All 
reported results on the effects of general anesthetics on other ion channels and 
receptors involved in brain functions (1-4, 6,7) can also be similarly explained. 
Further, it was reported recently that inhalational anesthetics block actin-
based motility in dendritic spines of the neurons and fibroblasts at clinically 
effective concentrations but do not influence actin polymerization in vitro (8). 
Thus, it seems that these anesthetics affect actin dynamics indirectly (8).  
According to the present hypothesis, the actin-based motility is probably affected 
through the oxygen-sensing mechanisms such as the release of modulating 
messengers or the depression of cellular metabolic activities. 
There is no direct experimental evidence, e.g., that obtained by applying 
any of the established essay methods such as radioligand-binding essay, 
supporting the proposition that anesthesia is the result of direct interactions 
between anesthetics and the ion channels and receptors involved in brain 
functions. Even those results obtained by site-directed mutagenesis techniques do 
not necessarily provide evidence to support such a proposition. Indeed, those 
results can also be satisfactorily explained according to the present hypothesis. 
For example, it has been reported that specific mutations of certain 
residues of GlyR and GABAA receptors can abolish or markedly reduce the effect 
of anesthetic or ethanol on these receptors without necessarily affecting receptor 
function seemingly suggesting that anesthetics and alcohols may bind in a cavity 
located on the receptor complex (56). However, according to the present 
hypothesis the binding to the above-said cavity by a modulating messenger 
released through the oxygen-sensing mechanisms in response to anesthetic-
induced hypoxia or hypoxia-mimic situations can also explained the observed 
effects. Alternatively, the observed effect can be explained by the binding of the 
above-said messenger to somewhere else in the receptor complex but the above-
said cavity provides a transduction or gating site required for the messenger’ s 
action. 
The only specific binding reported so far is the laboratory-created 
covalent binding between an anesthetic analog, propanethiol (a sulfhydryl-
specific reagent), and cysteine residues introduced into GlyR and GABAA 
receptors through site-directed mutagenesis techniques (57).  It was reported that 
such covalent binding irreversibly enhances receptor functions (57).  However, 
since such binding is artificially created, it does not prove direct binding of 
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anesthetics to these receptors. According to the present hypothesis, the observed 
effect can be explained as the irreversible occupation of the messenger binding 
site or the messenger-mediated transduction or gating site. 
 
OTHER IMPLICATIONS OF THE PRESENT HYPOTHESIS 
If the present hypothesis is correct, it has other significant implications in 
medicine and biology. Again, due to limited spaces, only a few important 
implications will be briefly discussed below. 
The mechanism by which alcohols exert their intoxicating effect is not 
well understood (58,59). However, it is known that ethanol and other short-chain 
alcohols are lipid-soluble and affect a variety of physiochemical structural 
properties of the biological membranes (see, e.g., 59). According to the present 
hypothesis, the intoxicating effect of alcohols is likely due to the cellular 
responses of the brain to mild hypoxia or hypoxia-mimic situations at sub-
cellular or molecular level caused by the perturbation of oxygen pathways in 
membranes and proteins by these alcohols. 
Second, the present hypothesis suggests the existence of endogenous 
modulating messengers responsible for producing general anesthesia through the 
oxygen-sensing mechanisms. Thus, some substances such as ketamine may 
produce anesthetic effect as messenger-mimic substances by direct binding to ion 
channels and receptors involved in brain functions. Ketamine is known to be a 
non-competitive antagonist of the NMDA receptor (60). If these endogenous 
messengers do exist, they may play very important roles in the normal functions 
of the brain such as regulations of sleep and consciousness. It has been 
speculated that the endogenous analogue of general anesthesia may exist (61). 
Third, some general anesthetics have been shown to have neural 
protective effect against ischemia, but the underlying mechanisms are unknown 
(62,63). It has been speculated that they produce such effect by acting as free 
radical scavengers (63). According to the present hypothesis, this effect is 
probably due to the perturbation of oxygen pathways in both membranes and 
proteins such that the neurons are in a depressed metabolic states and smaller 
amount of oxidative substances such as free radicals is generated upon 
reperfusion with oxygen. 
Finally, many side effects of general anesthetics including some toxic 
effects may be explained according to the proposed mechanism. The key 
pathological condition to be considered under the present hypothesis is hypoxia 
or hypoxia-mimic situations at sub-cellular or molecular level. Thus, overdose or 
other misuse of general anesthetics may cause necrosis in brain, liver or other 
vital organs of the body. Indeed, some published results indicate that certain 
anesthetics cause necrosis in the liver (64). 
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CONCLUSION 
We have proposed in this paper a novel unitary mechanism of general 
anesthesia verifiable by experiments. In the proposed mechanism, general 
anesthetics perturb oxygen pathways in both membranes and oxygen-utilizing 
proteins such that its availabilities to the sites of utilization are reduced which in 
turn triggers cascading cellular responses through oxygen-sensing mechanisms 
resulting in general anesthesia. The present hypothesis provides a unified 
framework for explaining phenomena associated with general anesthesia and 
experimental results on the actions of general anesthetics. If valid, the proposed 
mechanism also has other significant medical and biological implications. 
 
 
 
 
FIG. 1. Oxygen transport across cell membranes.  Oxygen has to diffuse 
through the plasma membrane and the outer and inner membranes of the 
mitochondria before it can reach the mitochondrial matrix (a). At each 
membrane, oxygen has to diffuse through a first polar surface region, a 
hydrophobic region and a second polar surface region (b). The free energy barrier 
for oxygen uptake is schematically shown (b). 
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 FIG. 2. Perturbation of oxygen pathways in membranes and proteins by 
general anesthetics. According to the present hypothesis, anesthetic molecules 
narrow, block, dislocate, distort or otherwise interfere with oxygen pathways in 
both membranes and proteins. They perturb not only oxygen transport across cell 
membranes but also its lateral movement within the membrane and the 
movement within a hydrophobic pocket of the protein. 
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 FIG. 3. Schematic diagram of the novel unitary mechanism of general 
anesthesia according to the present hypothesis. 
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